Statin benefits unaffected by baseline CRP levels 1 Feb 2011 0 comments Benefits of statin treatment in patients at high risk of cardiovascular events are unaffected by baseline levels of C-reactive protein, new data from the Heart Protection Study has suggested.
Monitoring cholesterol levels not evidence based 25 Jan 2011 0 comments Although clinical guidelines state that doctors should monitor patients’ cholesterol levels to assess medication adherence, this practice is of limited value and should only be used as an adjunct to…
